Should you buy EYE.AX stock?
Last updated:
Based on market data through , StockInvest.us rates Nova Eye Medical Limited (EYE.AX) as a Buy Candidate with a technical score of 4.44 on its -10 to +10 scale. This is an upgrade from Hold in the previous daily evaluation.
- Buy signal since
- Price since signal Up 12.14%
- 3-month trend forecast Up 14.22%
- High gross margin of 66.7%
- Highly efficient cash conversion (107% FCF/OCF ratio)
- Lower volatility than the market (beta 0.93)
Nova Eye Medical Limited stock upgraded to Buy Candidate
(Market data through Aug 11, 2026)
The Nova Eye Medical Limited stock price gained 4.67% on the last trading day (Tuesday, 11th Aug 2026), rising from A$0.150 to A$0.157. During the last trading day the stock fluctuated 4.67% from a day low at A$0.150 to a day high of A$0.157. The price has risen in 7 of the last 10 days and is up by 30.83% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 192 thousand more shares were traded than the day before. In total, 446 thousand shares were bought and sold for approximately A$70.03 thousand.
Given the current short-term trend, the stock is expected to rise 14.22% during the next 3 months and, with a 90% probability hold a price between A$0.126 and A$0.179 at the end of this 3-month period.
EYE.AX Signals & Forecast
Mostly positive signals in the chart today. The Nova Eye Medical Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at A$0.147 and A$0.122. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 24, 2026, and so far it has risen 57.00%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Nova Eye Medical Limited has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Nova Eye Medical Limited stock
On the downside, the stock finds support just below today's level from accumulated volume at A$0.135 and A$0.130. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Nova Eye Medical Limited finds support just below today's level at A$0.135. If this is broken, then the next support from accumulated volume will be at A$0.130 and A$0.120.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved A$0.0070 between high and low, or 4.67%. For the last week, the stock has had daily average volatility of 5.77%.
Our recommended stop-loss: A$0.151 (-3.76%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 34 days ago.)
Trading Expectations (EYE.AX) For The Upcoming Trading Day Of Wednesday 12th
For the upcoming trading day on Wednesday, 12th we expect Nova Eye Medical Limited to open at A$0.155, and during the day (based on 14 day Average True Range), to move between A$0.153 and A$0.161, which gives a possible trading interval of +/-A$0.0080 (+/-5.20%) up or down from last closing price. If Nova Eye Medical Limited takes out the full calculated possible swing range there will be an estimated 5.20% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ A$0.135, some A$0.0220 (14.01%) from the current price of A$0.157, our system finds the risk reward attractive.
Is Nova Eye Medical Limited stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Nova Eye Medical Limited stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.
Current score:
4.438
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on August 12, 2026 - A$0.155 ( 1.49%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
EYE.AX Performance
Trading levels for EYE.AX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.162 | 2.97% |
| R2 | 0.159 | 1.27% |
| R1 | 0.157 | 0.217% |
| Price | 0.157 | |
| S1 | 0.152 | -3.19% |
| S2 | 0.150 | -4.24% |
| S3 | 0.148 | -5.94% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 0.157 | |
| S1 | 0.135 | -14.01% |
| S2 | 0.130 | -17.20% |
| S3 | 0.120 | -23.57% |
EYE Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Jul 21, 2020 | Jul 21, 2020 | Jul 29, 2020 | A$0.414 | 0% |
| 2 | Jul 14, 2020 | Jul 14, 2020 | Jul 14, 2020 | A$0.290 | 0% |
| 3 | Dec 03, 2002 | Dec 03, 2002 | Dec 03, 2002 | A$0.0225 | 0% |
| 4 | Dec 02, 2002 | Dec 02, 2002 | Dec 02, 2002 | A$0.0225 | 0% |
FAQ
Click here for our free guide on how to buy Nova Eye Medical Limited Stock.
Buy EYE